Viral infections characterized by skin and mucous membrane lesions

AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

rubella: A viral infectious disease that results_in infection located_in skin, has_material_basis_in Rubella virus, which is transmitted_by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted_by congenital method. The infection has_symptom rash on the face which spreads to the trunk and limbs, has_symptom fever, has_symptom lymphadenopathy, has_symptom joint pains, has_symptom headache, and has_symptom conjunctivitis. [ url:http://en.wikipedia.org/wiki/Rubella ]

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 B00-B09
Hospital discharge: ICD-9 078[0-4]
Hospital discharge: ICD-8 079[0-1]
Hospital discharge: excluded ICD-9 0781C|0785|078[7-8]
Cause of death: ICD-10 B00-B09
Cause of death: ICD-9 078[0-4]
Cause of death: ICD-8 079[0-1]
Cause of death: excluded ICD-9 0781C|0785|078[7-8]

8505

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

8472

diagram downward connector

Check minimum number of events None

8472

diagram downward connector
AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Viral infections characterized by skin and mucous membrane lesions based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 10658 5766 4892
Unadjusted prevalence (%) 3.45 3.32 3.62
Mean age at first event (years) 42.48 43.90 40.80

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.58 [2.04, 3.28] 5.1e-15 840
15 years 0.01 1.37 [1.10, 1.71] 4.7e-3 330
5 years 0.00 3.10 [2.58, 3.73] 4.9e-33 271
1 year 0.00 7.52 [6.02, 9.41] 4.6e-70 140

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: AB1_VIRAL_SKIN_MUCOUS_MEMBRANE – Viral infections characterized by skin and mucous membrane lesions
GWS hits: 1

Survival analyses between endpoints

Plot

before Viral infections characterized by skin and mucous membrane lesions
after Viral infections characterized by skin and mucous membrane lesions

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Viral infections characterized by skin and mucous membrane lesions